Recombinant KRT20 antibody

Catalog No. ABIN7881389

The Rabbit Monoclonal anti-KRT20 antibody (Clone KRT20-4380R) (ABIN7881389) specifically detects KRT20 in IHC (p). The antibody is reactive with Human samples.

Quick Overview for Recombinant KRT20 antibody (ABIN7881389)

Target: KRT20 (Keratin 20 (KRT20))

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Rabbit

Clonality: Monoclonal

Conjugate: This KRT20 antibody is un-conjugated

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Clone: KRT20-4380R

Product Details anti-KRT20 Antibody

Purpose: Recombinant KRT20 Antibody / Cytokeratin 20

Purification: Protein A/G affinity

Immunogen: A portion of amino acids 324 424 was used as the immunogen for the recombinant KRT20 antibody.

Isotype: IgG, kappa

Application Details

Application Notes: Optimal dilution of the recombinant KRT20 antibody should be determined by the researcher.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 0.2 mg/mL

Buffer: 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Aliquot the recombinant KRT20 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Target Details for KRT20

Target: KRT20 (Keratin 20 (KRT20))

Alternative Name: KRT20

Background: This MAb recognizes an intermediate filament protein of 46 kDa, identified as CK20 (KRT20). KRT20 is abundantly expressed in goblet cells and enterocytes of the gastrointestinal tract. It is a useful marker of pancreatic and colorectal cancer. KRT20 is expressed under normal, hyperplastic and neoplastic conditions.It has been detected in adenocarcinomas of the colon, stomachand biliary tract. Breast carcinomas are generally non-reactive.

UniProt: P35900